Related references
Note: Only part of the references are listed.Circulating microenvironment of CLL: Are nurse-like cells related to tumor-associated macrophages?
Agata A. Filip et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo
Gloria Lutzny et al.
CANCER CELL (2013)
ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages
Yan Zhang et al.
CELL RESEARCH (2013)
In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors
Eleonora Fonte et al.
CLINICAL CANCER RESEARCH (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production
Maria Velegraki et al.
HAEMATOLOGICA (2013)
Serum HMGB1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma
Chiharu Tabata et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome
Paul Greaves et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rage signalling promotes intestinal tumourigenesis
J. Heijmans et al.
ONCOGENE (2013)
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
J. R. van Beijnum et al.
ONCOGENE (2013)
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Sandro Jube et al.
CANCER RESEARCH (2012)
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape
Jan A. Burger
CURRENT OPINION IN ONCOLOGY (2012)
DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature
Yue Li et al.
EMBO JOURNAL (2012)
The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death
Christian Beyer et al.
INNATE IMMUNITY (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Wan Zhang et al.
NATURE CELL BIOLOGY (2012)
The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia
Rui Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
Jose Augusto Nogueira-Machado et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Identification and manipulation of tumor associated macrophages in human cancers
Moniek Heusinkveld et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia
Loic Ysebaert et al.
LEUKEMIA & LYMPHOMA (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation
Tobias Haas et al.
IMMUNITY (2008)
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
Y. Komohara et al.
JOURNAL OF PATHOLOGY (2008)
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Dorothee Duluc et al.
BLOOD (2007)
The grateful dead:: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity
Michael T. Lotze et al.
IMMUNOLOGICAL REVIEWS (2007)
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Stanimir Ivanov et al.
BLOOD (2007)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis
Derek C. Angus et al.
CRITICAL CARE MEDICINE (2007)
High mobility group box 1 protein interacts with multiple Toll-like receptors
JS Park et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
M Nishio et al.
BLOOD (2005)
Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells
IE Dumitriu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
HMGB1 is an endogenous immune adjuvant released by necrotic cells
P Rovere-Querini et al.
EMBO REPORTS (2004)
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
C Murdoch et al.
BLOOD (2004)
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway
S Gardella et al.
EMBO REPORTS (2002)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Distinctive features of nurselike cells that differentiate in the context of chronic lymphocytic leukemia
N Tsukada et al.
BLOOD (2002)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Share Paper
